Shrinkage by the third month predicts long-term response of macroprolactinoma after cabergoline.
Betina BiagettiSilvana Sarria-EstradaYiken Karelys Ng-WongElena Martinez-SaezAnna CasteràsEsteban Cordero AsanzaIrene HernandezMarina Giralt-ArnaizRafael SimòPublished in: European journal of endocrinology (2021)
Tumour shrinkage in the first 3-4 months after starting treatment with CBG is a good tool for predicting the long-term response and can help clinicians to take more appropriated and personalized decisions.
Keyphrases